| 
 | ||||||||||||||||||||
| 
 | |
| 
 | Phenotypic Information (metabolism pathway, cancer, disease, phenome) | 
| 
 | |
| 
 | |
| 
 | Gene-Gene Network Information: Co-Expression Network, Interacting Genes & KEGG | 
| 
 | |
| 
 | 
| Gene Summary for RRM2 | 
| Basic gene info. | Gene symbol | RRM2 | 
| Gene name | ribonucleotide reductase M2 | |
| Synonyms | R2|RR2|RR2M | |
| Cytomap | UCSC genome browser: 2p25-p24 | |
| Genomic location | chr2 :10262862-10271546 | |
| Type of gene | protein-coding | |
| RefGenes | NM_001034.3, NM_001165931.1, | |
| Ensembl id | ENSG00000171848 | |
| Description | ribonucleoside-diphosphate reductase subunit M2ribonucleotide reductase M2 polypeptideribonucleotide reductase small chainribonucleotide reductase small subunit | |
| Modification date | 20141222 | |
| dbXrefs | MIM : 180390 | |
| HGNC : HGNC | ||
| Ensembl : ENSG00000171848 | ||
| HPRD : 01587 | ||
| Vega : OTTHUMG00000090449 | ||
| Protein | UniProt: go to UniProt's Cross Reference DB Table | |
| Expression | CleanEX: HS_RRM2 | |
| BioGPS: 6241 | ||
| Gene Expression Atlas: ENSG00000171848 | ||
| The Human Protein Atlas: ENSG00000171848 | ||
| Pathway | NCI Pathway Interaction Database: RRM2 | |
| KEGG: RRM2 | ||
| REACTOME: RRM2 | ||
| ConsensusPathDB | ||
| Pathway Commons: RRM2 | ||
| Metabolism | MetaCyc: RRM2 | |
| HUMANCyc: RRM2 | ||
| Regulation | Ensembl's Regulation: ENSG00000171848 | |
| miRBase: chr2 :10,262,862-10,271,546 | ||
| TargetScan: NM_001034 | ||
| cisRED: ENSG00000171848 | ||
| Context | iHOP: RRM2 | |
| cancer metabolism search in PubMed: RRM2 | ||
| UCL Cancer Institute: RRM2 | ||
| Assigned class in ccmGDB | C | |
| Top | 
| Phenotypic Information for RRM2(metabolism pathway, cancer, disease, phenome) | 
|  Cancer Description | |
| Cancer | CGAP: RRM2 | 
| Familial Cancer Database: RRM2 | |
| * This gene is included in those cancer gene databases. | 
| 
 | 
 | 
 | 
 | 
 | 
 | 
 | ||||||||||||||
| Oncogene 1 | Significant driver gene in | |||||||||||||||||||
| cf) number; DB name 1 Oncogene; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 2 Tumor Suppressor gene; https://bioinfo.uth.edu/TSGene/, 3 Cancer Gene Census; http://www.nature.com/nrc/journal/v4/n3/abs/nrc1299.html, 4 CancerGenes; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 5 Network of Cancer Gene; http://ncg.kcl.ac.uk/index.php, 1Therapeutic Vulnerabilities in Cancer; http://cbio.mskcc.org/cancergenomics/statius/ | 
|  Metabolic Pathway Description | |
| KEGG_PURINE_METABOLISM KEGG_PYRIMIDINE_METABOLISM KEGG_GLUTATHIONE_METABOLISM REACTOME_METABOLISM_OF_NUCLEOTIDES | |
|  Others | |
| OMIM | |
| Orphanet | |
| Disease | KEGG Disease: RRM2 | 
| MedGen: RRM2 (Human Medical Genetics with Condition) | |
| ClinVar: RRM2 | |
| Phenotype | MGI: RRM2 (International Mouse Phenotyping Consortium) | 
| PhenomicDB: RRM2 | |
| Mutations for RRM2 | 
| * Under tables are showing count per each tissue to give us broad intuition about tissue specific mutation patterns.You can go to the detailed page for each mutation database's web site. | 
|  Structural Variants in COSMIC: go to COSMIC mutation histogram | 
| There's no structural variation information in COSMIC data for this gene. | 
|  Related fusion transcripts : go to Chitars2.0 | 
| * From mRNA Sanger sequences, Chitars2.0 arranged chimeric transcripts. This table shows RRM2 related fusion information. | 
| ID | Head Gene | Tail Gene | Accession | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a | 
| BQ379268 | ADD1 | 36 | 92 | 4 | 2931732 | 2931788 | RRM2 | 81 | 300 | 2 | 10263875 | 10264958 | |
| DB124334 | CDH3 | 1 | 437 | 16 | 68678846 | 68679282 | RRM2 | 434 | 555 | 2 | 10263171 | 10263621 | |
| AA826373 | RRM2 | 1 | 389 | 2 | 10271152 | 10271540 | NCKAP1 | 384 | 515 | 2 | 183866687 | 183866901 | |
|  Other DBs for Structural Variants | 
| Top | 
|  Copy Number Variations in COSMIC: go to COSMIC mutation CNV/Expr | 
| There's no copy number variation information in COSMIC data for this gene. | 
| Top | 
|  SNV Counts per Each Loci in COSMIC data: go to COSMIC point mutation | 
|   | 
|  | 
| Top | 
|  Somatic Mutation Counts per Tissue in COSMIC data | 
| Stat. for Non-Synonymous SNVs (# total SNVs=24) | (# total SNVs=7) | 
|  |  | 
| (# total SNVs=2) | (# total SNVs=0) | 
|  | 
| Top | 
|  Top 10 SNVs Having the Most Samples in COSMIC data | 
| * When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site,primary_histology,mutation(aa),pubmedID. | 
| GRCh37 position | Mutation(aa) | Unique sampleID count | 
| chr2:10269209-10269209 | p.M315I | 2 | 
| chr2:10262969-10262969 | p.Q15R | 2 | 
| chr2:10264910-10264910 | p.M168V | 1 | 
| chr2:10263127-10263127 | p.G39G | 1 | 
| chr2:10269069-10269069 | p.R298Q | 1 | 
| chr2:10263628-10263628 | p.A97T | 1 | 
| chr2:10269426-10269426 | p.F361L | 1 | 
| chr2:10264927-10264927 | p.S173S | 1 | 
| chr2:10263526-10263526 | p.A63S | 1 | 
| chr2:10269168-10269168 | p.E302K | 1 | 
| Top | 
|  SNV Counts per Each Loci in TCGA data | 
|   | 
|  | 
| Point Mutation/ Tissue ID | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 
| # sample | 3 | 2 | 1 | 4 | 1 |   |   |   | 1 |   |   | 5 | 1 |   |   |   | 2 | 3 |   | 7 | 
| # mutation | 3 | 2 | 1 | 4 | 1 |   |   |   | 1 |   |   | 6 | 1 |   |   |   | 2 | 3 |   | 7 | 
| nonsynonymous SNV | 2 | 1 |   | 4 | 1 |   |   |   | 1 |   |   | 5 | 1 |   |   |   | 1 | 3 |   | 7 | 
| synonymous SNV | 1 | 1 | 1 |   |   |   |   |   |   |   |   | 1 |   |   |   |   | 1 |   |   |   | 
| cf) Tissue ID; Tissue type (1; BLCA[Bladder Urothelial Carcinoma], 2; BRCA[Breast invasive carcinoma], 3; CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], 4; COAD[Colon adenocarcinoma], 5; GBM[Glioblastoma multiforme], 6; Glioma Low Grade, 7; HNSC[Head and Neck squamous cell carcinoma], 8; KICH[Kidney Chromophobe], 9; KIRC[Kidney renal clear cell carcinoma], 10; KIRP[Kidney renal papillary cell carcinoma], 11; LAML[Acute Myeloid Leukemia], 12; LUAD[Lung adenocarcinoma], 13; LUSC[Lung squamous cell carcinoma], 14; OV[Ovarian serous cystadenocarcinoma ], 15; PAAD[Pancreatic adenocarcinoma], 16; PRAD[Prostate adenocarcinoma], 17; SKCM[Skin Cutaneous Melanoma], 18:STAD[Stomach adenocarcinoma], 19:THCA[Thyroid carcinoma], 20:UCEC[Uterine Corpus Endometrial Carcinoma]) | 
| Top | 
|  Top 10 SNVs Having the Most Samples in TCGA data | 
| * We represented just top 10 SNVs. When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site, primary_histology, mutation(aa), pubmedID. | 
| Genomic Position | Mutation(aa) | Unique sampleID count | 
| chr2:10269209 | p.G39G,RRM2 | 1 | 
| chr2:10263000 | p.K278K,RRM2 | 1 | 
| chr2:10264898 | p.A64D,RRM2 | 1 | 
| chr2:10269216 | p.R298W,RRM2 | 1 | 
| chr2:10263127 | p.L73L,RRM2 | 1 | 
| chr2:10264910 | p.R298Q,RRM2 | 1 | 
| chr2:10269234 | p.H88N,RRM2 | 1 | 
| chr2:10263530 | p.E302K,RRM2 | 1 | 
| chr2:10267090 | p.D89G,RRM2 | 1 | 
| chr2:10269260 | p.M315I,RRM2 | 1 | 
|  Other DBs for Point Mutations | 
|  Copy Number for RRM2 in TCGA | 
| * Copy number data were extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered on Jan-05-2015. Function ProcessCNAData in TCGA-Assembler package was used to obtain gene-level copy number value which is calculated as the average copy number of the genomic region of a gene. | 
|  | 
| cf) Tissue ID[Tissue type]: BLCA[Bladder Urothelial Carcinoma], BRCA[Breast invasive carcinoma], CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], COAD[Colon adenocarcinoma], GBM[Glioblastoma multiforme], Glioma Low Grade, HNSC[Head and Neck squamous cell carcinoma], KICH[Kidney Chromophobe], KIRC[Kidney renal clear cell carcinoma], KIRP[Kidney renal papillary cell carcinoma], LAML[Acute Myeloid Leukemia], LUAD[Lung adenocarcinoma], LUSC[Lung squamous cell carcinoma], OV[Ovarian serous cystadenocarcinoma ], PAAD[Pancreatic adenocarcinoma], PRAD[Prostate adenocarcinoma], SKCM[Skin Cutaneous Melanoma], STAD[Stomach adenocarcinoma], THCA[Thyroid carcinoma], UCEC[Uterine Corpus Endometrial Carcinoma] | 
| Top | 
| Gene Expression for RRM2 | 
|  Gene Expression in Cancer Cell-lines (CCLE) | 
| * CCLE gene expression data were extracted from CCLE_Expression_Entrez_2012-10-18.res: Gene-centric RMA-normalized mRNA expression data. | 
|  | 
|  Differential Gene Expression in Primary Tumors (TCGA) | 
| * Normalized gene expression data of RNASeqV2 was extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered at Jan-05-2015. Only eight cancer types have enough normal control samples for differential expression analysis. (t test, adjusted p<0.05 (using Benjamini-Hochberg FDR)) | 
|  | 
| Top | 
|  CNV vs Gene Expression Plot | 
| * This plots show the correlation between CNV and gene expression. | 
|  | 
 | 
|  | 
 | 
| Top | 
| Gene-Gene Network Information | 
|  Co-Expressed gene's network Plot | 
| * Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene | 
|  | 
 | ||||
| ANKRD46,ARFGEF1,ATP6V1C1,AZIN1,TRIQK,CPNE3,DPY19L4, EBAG9,RMDN1,FAM91A1,KIAA0196,MTDH,RRM2B,SPAG1, STAU2,EMC2,UBE2W,UBR5,VPS13B,WWP1,ZNF252P | AHCYL2,CAB39,CUL5,EFR3A,EGLN1,FBXL17,FBXO3, FYTTD1,HCN1,IBTK,IDE,KIAA0232,KPNA1,PPTC7, RPS6KA3,RRM2B,STAU2,STRN3,SYNJ2BP,USP38,WDR47 | ||||
|  | 
 | ||||
| ATP6V1C1,ANKUB1,CPNE3,FAM91A1,GRM5,GUCA1C,IL1RL1, KHDC1L,KIAA0196,KRT1,MTDH,NBN,OR10H4,OSGIN2, PCDH9,PLGLA,RIPK2,RRM2B,STK3,TRAM1,UTS2B | PXYLP1,ALDH7A1,CCDC112,CNOT7,CPNE3,HSDL2,KCNE2, LINC01512,LRPPRC,MEST,METTL15,PLEKHG7,PRSS30P,RRM2B, SKAP2,SLC12A2,STARD7,THNSL1,UPRT,WARS2,ZBTB44 | 
|  Co-Expressed gene's Protein-protein interaction Network Plot | 
| * Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene | 
| Top | 
|  Interacting Genes (from Pathway Commons) | 
| Top | 
| Pharmacological Information for RRM2 | 
|  Cross-referenced pharmacological DB IDs from Uniprot | 
| DB Category | DB Name | DB's ID and Url link | 
|  Drug-Gene Interaction Network | 
| * Gene Centered Interaction Network. | 
|  | 
| * Drug Centered Interaction Network. | 
| DrugBank ID | Target Name | Drug Groups | Generic Name | Drug Centered Network | Drug Structure | 
| DB00242 | ribonucleotide reductase M2 | approved; investigational | Cladribine |  |  | 
| DB05260 | ribonucleotide reductase M2 | approved; investigational | Gallium nitrate |  |  | 
| DB00987 | ribonucleotide reductase M2 | approved; investigational | Cytarabine |  |  | 
| DB01101 | ribonucleotide reductase M2 | approved; investigational | Capecitabine |  |  | 
| DB00544 | ribonucleotide reductase M2 | approved | Fluorouracil |  |  | 
| DB00130 | ribonucleotide reductase M2 | approved; nutraceutical; investigational | L-Glutamine |  |  | 
| DB00441 | ribonucleotide reductase M2 | approved | Gemcitabine |  |  | 
| DB00515 | ribonucleotide reductase M2 | approved | Cisplatin |  |  | 
| DB01050 | ribonucleotide reductase M2 | approved | Ibuprofen |  |  | 
| Top | 
| Cross referenced IDs for RRM2 | 
| * We obtained these cross-references from Uniprot database. It covers 150 different DBs, 18 categories. http://www.uniprot.org/help/cross_references_section | 
|             Copyright © 2016-Present - The Univsersity of Texas Health Science Center at Houston @ |